Skip to main content
Back
RHKJF logo

Rhoen-Klinikum AG

Data quality: 100%
Overbought
RHKJF
OTC Healthcare Medical - Care Facilities
$15.30
$0.00 (0.00%)
Mkt Cap: 1.02B
Day Range
$15.30 $15.30
52-Week Range
$11.15 $15.30
Volume
893
50D / 200D Avg
$15.30 / $15.30
Prev Close
$15.30

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (633 peers)

Metric Stock Sector Median
P/E 29.7 0.2
P/B 0.8 2.8
ROE % 2.6 3.8
Net Margin % 1.8 3.9
Rev Growth 5Y % 5.0 10.0
D/E 0.1 0.2

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2029 $1.05
$1.05 – $1.05
2.04B 1
FY2028 $0.94
$0.94 – $0.94
1.94B 1
FY2027 $0.84
$0.84 – $0.84
1.85B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2025-08-07 N/A $0.12
2025-05-08 N/A $0.12
2025-03-27 N/A $0.23
2024-11-07 N/A $0.16
2024-08-08 N/A $0.15
2024-05-08 N/A $0.17
2024-03-28 N/A $0.26
2023-09-30 N/A $0.18

Dividend History

3 yr streak

Yield

0.01%

Payout Ratio

0.19%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Jun 05, 2025 Jun 06, 2025 $0.11 0.75%
Jun 08, 2023 Jun 13, 2023 $0.16 1.17%
Jun 06, 2019 Jun 11, 2019 $0.33 1.16%
Jun 07, 2018 Jun 11, 2018 $0.26 0.78%
Jun 08, 2017 Jun 12, 2017 $0.39 1.46%
Jun 09, 2016 Jun 09, 2016 $0.91 3.06%
Jun 11, 2015 Jun 11, 2015 $0.90 3.49%
Jun 13, 2014 Jun 13, 2014 $0.34 1.13%
Jun 13, 2013 Jun 13, 2013 $0.33 1.42%
Jun 14, 2012 Jun 14, 2012 $0.57 2.47%
Jun 09, 2011 Jun 09, 2011 $0.54 2.17%
Jun 10, 2010 Jun 10, 2010 $0.36 1.66%
Jun 11, 2009 Jun 11, 2009 $0.49 2.46%
Jun 18, 2008 Jun 18, 2008 $0.44 1.42%
Jun 01, 2007 Jun 01, 2007 $0.67 0.55%
Jul 20, 2006 Jul 20, 2006 $0.57 0.64%
Jul 21, 2005 Jul 21, 2005 $1.92 1.35%
Jul 23, 2004 Jul 23, 2004 $1.69 1.42%
Jul 17, 2003 Jul 17, 2003 $1.32 1.11%
Jul 18, 2002 Jul 18, 2002 $0.99 0.83%

Key Takeaways

Revenue grew 5.01% annually over 5 years — modest growth
Earnings declined -20.51% over the past year
ROE of 2.63% is below average
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -34.59M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 16.26%

Growth

Revenue Growth (5Y)
5.01%
Revenue (1Y)21.27%
Earnings (1Y)-20.51%
FCF Growth (3Y)N/A

Quality

Return on Equity
2.63%
ROIC0.23%
Net Margin1.78%
Op. Margin0.23%

Safety

Debt / Equity
0.09
Current Ratio2.60
Interest Coverage1.46

Valuation

P/E Ratio
29.72
Forward P/E20.45
P/B Ratio0.78
EV/EBITDA222.23
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 21.27% Revenue Growth (3Y) 5.61%
Earnings Growth (1Y) -20.51% Earnings Growth (3Y) -5.65%
Revenue Growth (5Y) 5.01% Earnings Growth (5Y) 5.05%
Profitability
Revenue (TTM) 1.93B Net Income (TTM) 34.46M
ROE 2.63% ROA 1.89%
Gross Margin 8.67% Operating Margin 0.23%
Net Margin 1.78% Free Cash Flow (TTM) -34.59M
ROIC 0.23% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.09 Current Ratio 2.60
Interest Coverage 1.46
Dividends
Dividend Yield 0.01% Payout Ratio 0.19%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 3 yrs
Valuation
P/E Ratio 29.72 Forward P/E 20.45
P/B Ratio 0.78 P/S Ratio 0.53
PEG Ratio -1.06 Forward PEG N/A
EV/EBITDA 222.23 Fwd EV/EBITDA 8.12
Forward P/S 0.58 Fwd Earnings Yield 4.89%
FCF Yield -3.38%
Market Cap 1.02B Enterprise Value 976.09M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.93B 1.60B 1.73B 1.45B 1.59B
Net Income 34.46M 43.35M 38.71M 25.14M 28.30M
EPS (Diluted) 0.51 0.67 0.58 0.38 0.42
Gross Profit 167.68M 171.82M 202.88M 999.52M 182.63M
Operating Income 4.39M 48.15M 40.40M 36.11M 30.52M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.82B 1.86B 1.77B 1.70B 1.67B
Total Liabilities 467.32M 530.51M 490.30M 453.51M 440.82M
Shareholders' Equity 1.32B 1.30B 1.25B 1.22B 1.20B
Total Debt 122.12M 149.60M 149.90M 158.20M 159.76M
Cash & Equivalents 170.19M 279.86M 206.04M 77.33M 126.32M
Current Assets 890.12M 904.11M 789.21M 688.61M 611.08M
Current Liabilities 341.70M 404.85M 335.47M 291.08M 273.31M

Strategy Scores

This stock passed the criteria for 0 strategies

Score = fit strength (0–100)
Rank = position among all matches

Recent Activity

Exited Deep Value Investing (Seth Klarman)
Mar 28, 2026
Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026